Pear therapeutics to participate in the 2023 btig medtech, digital health, life science & diagnostic tools conference

Boston--( business wire )--pear therapeutics, inc. (nasdaq: pear), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (pdts), today announced the company will participate in the btig medtech, digital health, life science & diagnostic tools conference, which takes place february 14 - 16, 2023 in snowbird, ut. pear management will participate virtually in 1x1 meetings at the conference.
PEAR Ratings Summary
PEAR Quant Ranking